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EDITORIALBrush Border Destruction by Enterohemorrhagic Escherichia coli
(EHEC): New Insights From Organoid Culturehe microvillus-rich brush border found at the apexTof enterocytes and colonocytes serves as the gut’s
functional interface, playing roles in nutrient processing,
solute transport, and host defense.1 Infectious or inherited
diseases that impact the function of this organelle have
signiﬁcant effects on gut homeostasis and can lead to death
in susceptible populations. An important example is pro-
vided by disease-causing, gram-negative attaching/effacing
(A/E) pathogens, which have evolved efﬁcient mechanisms
for destroying the brush border during efforts to promote
their own survival.2
Enterohemorrhagic Escherichia coli serotype O157:H7
(EHEC) is one A/E pathogen that represents a major cause
of food-borne enteric infection in North America, leading to
hundreds of deaths per year.3 Once in the gastrointestinal
tract, EHEC preferentially colonizes the proximal colon.
EHEC illness is at least partially caused by release of Shiga
toxin, which poisons multiple organ systems, but there also
are direct effects on the colonic epithelium. EHEC uses a
type III secretion system to inject colonocytes with viru-
lence factors that stimulate a massive remodeling of the
apical actin cytoskeleton. This leads to formation of
adherent pedestals that allow these bugs to remain tightly
associated with the epithelium and establish microcolonies.
Although Shiga toxins and pedestal formation have been the
focus of intense study for years, how EHEC establishes
initial contact with the epithelium and the subsequent dy-
namics of effacement remain poorly understood. This gap
has persisted in part owing to a lack of model systems that
faithfully recapitulate human colonocyte biology.
However, the advent of organoid culture in recent years
has fundamentally changed how biologists think about
cultured cell experiments.4 Gut organoids are cultured
either from stem cells or stem cell–containing crypts iso-
lated from small intestine or colon, derived from mice or
humans. These primary cultures are grown in a basement
membrane substrate and can be induced to differentiate,
building a crypt-villus axis similar to that observed in vivo.
Although gut organoids have already proven their utility in
studies of stem cell maintenance and human diseases,5,6 a
major limitation relates to their shape; organoids are cyst-
like, consisting of a single layer of epithelial cells sur-
rounding a hollow lumen. This closed system limits access
to the apical surface of the epithelium and also presents
major challenges for light microscopy.
In the current issue of Cellular and Molecular Gastro-
enterology and Hepatology, In et al7 describe an approach
for ﬂattening human colonoid cultures into monolayers, to
enable mechanistic studies of EHEC infection. After initial
growth, human colonoids are coaxed into monolayers byCseeding on ﬁlter substrates coated with collagen. The
resulting cultures show biochemical and morphologic
hallmarks of differentiated colonocytes, including assembly
of a well-organized apical brush border and copious mucus
secretion. Importantly, growth of organoids as monolayers
allows unfettered access to the apical surface, and clearer
microscopic imaging with cells limited to a single plane.
Other groups also recently developed colonoid mono-
layers,8 suggesting that this approach represents a robust,
next-generation gut epithelial biology model system.
In et al7 took advantage of human colonoid monolayers
to examine the early stages of EHEC contact with mono-
layers and generate new insights on infection. The initial
target of EHEC appears to be the Mucin-2 (MUC2)-enriched
mucus layer, which could serve as both an energy source
and substrate for initial attachment. Indeed, exposure to
EHEC signiﬁcantly reduced MUC2 levels on the surface of
colonoid monolayers. Intriguingly, the authors also found
that EHEC disrupts protocadherin-24 (PCDH24)-dependent
intermicrovillar adhesion, which was recently discovered to
be a critical driver of microvillar packing during brush-
border assembly.9 In et al7 observed robust PCDH24
expression and apical localization in colonoid cultures, and
showed that PCDH24 levels decrease signiﬁcantly in
response to infection. Using genetically modiﬁed variants of
EHEC, the authors also established that the secreted serine
protease, EspP, is the culprit enzyme responsible for loss of
PCDH24. Without EspP, EHEC is unable to induce pertur-
bations to colonoid brush borders. Finally, the authors
showed that addition of puriﬁed EspP to the surface of
colonoid monolayers is sufﬁcient for PCDH24 degradation.
Together these results suggest that a key step in EHEC-
induced microvillar effacement is loss of intermicrovillar
adhesion, caused by EspP-mediated degradation of PCDH24.
These results are fascinating for several reasons. This
report shows that intermicrovillar adhesion molecules are
targeted by EHEC’s pathogenic mechanism. This connection
makes biological sense given that perturbations in brush-
border morphology induced by loss of intermicrovillar
adhesion complexes9 phenocopy those induced by EHEC
infection. These data further suggest that adhesion between
microvilli provides a physical barrier to infection. Elimi-
nating this barrier and opening gaps between adjacent
microvilli might allow EHEC to make closer and more
continuous contact with the apical membrane, ultimately
promoting A/E lesion formation. This would be reminiscent
of previous work showing that splaying of brush-border
microvilli is a key step in the uptake of commensal mi-
crobes.10 Because initial studies on intermicrovillar adhe-
sion also established a potential link between PCDH24ellular and Molecular Gastroenterology and Hepatology 2016;2:7–8
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degradation of PCDH24 also might represent the ﬁrst step
in remodeling the apical actin network into A/E lesions.
Future studies along these lines will need to focus on clar-
ifying the molecular relationship between EHEC-induced
PCDH24 degradation, type III secretion system function,
and A/E lesion formation.
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